Analysts Viewpoint BCYC’s latest rating updates from top analysts. In a filing, Bicycle Therapeutics Plc ADR revealed its CHIEF EXECUTIVE OFFICER Lee Kevin unloaded Company’s shares for reported $23756.0
Stock Earnings Bicycle Therapeutics Plc ADR [BCYC] stock was sold by Young Alethia at the price of US$1724.0 Bicycle Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Young Alethia unloaded Company’s shares for reported $1724.0